Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WUBA
1326
CALL
DELISTED
58.com Inc
WUBA
| $12.9M | 0.01% |
270,100
+123,300
| +84% | +$6.02M |
|
1327
PUT
US Bancorp
USB
$97.2B
| $12.9M | 0.01% |
299,800
-846,900
| -74% | -$36M |
|
1328
PUT
Southern Copper
SCCO
$186B
| $12.8M | 0.01% |
532,292
-26,746
| -5% | -$638K |
|
|
SHLD
1329
CALL
DELISTED
Sears Holding Corporation
SHLD
| $12.8M | 0.01% |
1,118,700
-28,200
| -2% | -$397K |
|
1330
Annaly Capital Management
NLY
$17.4B
| $12.8M | 0.01% |
304,999
+297,482
| +3,957% | +$12.9M |
|
|
LL
1331
DELISTED
LL Flooring Holdings, Inc.
LL
| $12.8M | 0.01% |
651,039
+116,028
| +22% | +$1.9M |
|
1332
CALL
Assured Guaranty
AGO
$3.3B
| $12.8M | 0.01% |
461,400
-174,200
| -27% | -$4.7M |
|
1333
CALL
Bath & Body Works
BBWI
$3.54B
| $12.8M | 0.01% |
223,526
-23,998
| -10% | -$1.41M |
|
|
CIT
1334
PUT
DELISTED
CIT Group Inc.
CIT
| $12.7M | 0.01% |
350,900
+135,100
| +63% | +$4.72M |
|
1335
PUT
ProShares UltraPro S&P 500
UPRO
$5.5B
| $12.7M | 0.01% |
1,035,000
-209,400
| -17% | -$2.55M |
|
1336
PUT
ResMed
RMD
$34.1B
| $12.7M | 0.01% |
195,900
+68,900
| +54% | +$4.59M |
|
1337
CALL
Abercrombie & Fitch
ANF
$4.84B
| $12.7M | 0.01% |
798,600
+256,000
| +47% | +$4.94M |
|
1338
Vanguard FTSE All-World ex-US ETF
VEU
$71B
| $12.7M | 0.01% |
279,284
+258,941
| +1,273% | +$11.6M |
|
|
FITB
1339
CALL
Fifth Third Bancorp
FITB
$49.8B
| $12.7M | 0.01% |
620,000
+50,400
| +9% | +$973K |
|
|
1340
PUT
Annaly Capital Management
NLY
$17.4B
| $12.6M | 0.01% |
300,075
+17,375
| +6% | +$753K |
|
1341
CALL
Leidos
LDOS
$16.9B
| $12.6M | 0.01% |
290,600
+254,200
| +698% | +$11.5M |
|
1342
PUT
ICICI Bank
IBN
$109B
| $12.6M | 0.01% |
1,850,640
+518,320
| +39% | +$3.61M |
|
|
CS
1343
PUT
DELISTED
Credit Suisse Group
CS
| $12.5M | 0.01% |
954,500
+211,400
| +28% | +$2.56M |
|
1344
PUT
ProShares UltraShort QQQ
QID
$219M
| $12.5M | 0.01% |
6,464
+550
| +9% | +$1.14M |
|
1345
PUT
Helmerich & Payne
HP
$4.21B
| $12.5M | 0.01% |
186,300
+66,100
| +55% | +$4.15M |
|
1346
CALL
The Greenbrier Companies
GBX
$1.43B
| $12.5M | 0.01% |
354,200
+30,700
| +9% | +$1M |
|
|
RAD
1347
DELISTED
Rite Aid Corporation
RAD
| $12.5M | 0.01% |
81,069
-2,504
| -3% | -$374K |
|
1348
CF Industries
CF
$19.3B
| $12.5M | 0.01% |
511,822
+22,661
| +5% | +$553K |
|
|
STJ
1349
CALL
DELISTED
St Jude Medical
STJ
| $12.5M | 0.01% |
156,100
+75,000
| +92% | +$6.05M |
|
1350
CALL
Trane Technologies
TT
$100B
| $12.4M | 0.01% |
183,000
+107,500
| +142% | +$7.16M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.